NCT07299084
- Conditions
- Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +10 more
- Locations
-
- Lilly Centre for Clinical Pharmacology Singapore
Clinical trial condition
Overweight
Explore clinical trials studying Overweight. Study availability and eligibility vary by location and protocol.
1,143 public trials
82 recruiting studies
Overweight trial results
NCT06965413
- Conditions
- Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases, +6 more
- Locations
-
- Pinnacle Research Group Anniston, Alabama, United States
- Encompass Clinical Research Spring Valley, California, United States
- K2 Medical Research-Winter Garden Clermont, Florida, United States
- Rophe Adult and Pediatric Medicine/SKYCRNG Union City, Georgia, United States
Active, Not Recruiting
A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease （MAFLD）
NCT06884293
- Conditions
- Body Weight, Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD), Nutrition Disorders, +5 more
- Locations
-
- Beijing Hospital Beijing, Beijing Municipality, China
Active, Not Recruiting
A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight
NCT06914895
- Conditions
- Autoimmune Diseases, Body Weight, Diabetes Mellitus, +13 more
- Locations
-
- Sansum Diabetes Research Institute Santa Barbara, California, United States
- Care Access - Santa Clarita Santa Clarita, California, United States
- University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
- Atlanta Diabetes Associates Atlanta, Georgia, United States
Active, Not Recruiting
A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
NCT05536804
- Conditions
- Body Weight, Chronic Disease, Chronic Kidney Disease, +24 more
- Locations
-
- Valley Clinical Trials, Inc. Northridge, California, United States
- University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
- Kidney Associates of Colorado Denver, Colorado, United States
- American Health Network of Indiana, LLC - Avon Avon, Indiana, United States
Active, Not Recruiting
A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity
NCT07184632
- Conditions
- Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases, +5 more
- Locations
-
- Celerion, Phoenix Tempe, Arizona, United States
- Celerion, Lincoln Lincoln, Nebraska, United States
Active, Not Recruiting
Treatment of Overweight in Children on Distance
NCT02720302
- Conditions
- Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases, +4 more
- Locations
-
- Barnmedicin Malmö, Skåne County, Sweden
Active, Not Recruiting
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
NCT06993792
- Conditions
- Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +11 more
- Locations
-
- Clinical Research Institute of Arizona (CRI) - Sun City West Sun City West, Arizona, United States
- Novak Clinical Research - Tucson - North La Cholla Boulevard Tucson, Arizona, United States
- Norcal Endocrinology & Internal Medicine San Ramon, California, United States
- Southern California Clinical Research Santa Ana, California, United States
Active, Not Recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
NCT06972459
- Conditions
- Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases, +5 more
- Locations
-
- Clinical Research Institute of Arizona (CRI) - Sun City West Sun City West, Arizona, United States
- Novak Clinical Research - Tucson - North La Cholla Boulevard Tucson, Arizona, United States
- Norcal Endocrinology & Internal Medicine San Ramon, California, United States
- Southern California Clinical Research Santa Ana, California, United States
Active, Not Recruiting
Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide
NCT07220759
- Conditions
- Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +11 more
- Locations
-
- Univ of Alabama_Birmingham Birmingham, Alabama, United States
- Chambliss Clinical Trials, LLC Montgomery, Alabama, United States
- Elite Clinical Network - Tucson Tucson, Arizona, United States
- Scripps Whittier Diabetes Inst La Jolla, California, United States